{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:47:11Z","timestamp":1775620031567,"version":"3.50.1"},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.2169\/internalmedicine.2515-18","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T22:11:23Z","timestamp":1553724683000},"page":"2207-2211","source":"Crossref","is-referenced-by-count":4,"title":["Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"58","author":[{"given":"Atsuki","family":"Fukada","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Toyoshima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nozue","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Hamamatsu Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Negishi M, Kaga S, Kasama T, et al. Lung injury associated with bucillamine therapy. Ryumachi 32: 135-139, 1992 (in Japanese, Abstract in English)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Shimizu H, Ichikawa Y, Takaya M, et al. Acute interstitial pneumonitis induced by bucillamine in a patient with rheumatoid arthritis. Jpn J Clin Immunol 14: 174-180, 1991 (in Japanese, Abstract in English).","DOI":"10.2177\/jsci.14.174"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kurashima K, Nakao S, Fujimura M, Matsuda T. Bucillamine-induced hypersensitivity pneumonitis. Chest 101: 1479-1480, 1992.","DOI":"10.1378\/chest.101.5.1479-c"},{"key":"4","unstructured":"4. Hara A, Sakamoto O, Matsumoto M, et al. A case of bucillamine-induced interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi (J Jpn Respir Soc) 30: 1743-1748, 1992 (in Japanese, Abstract in English)."},{"key":"5","unstructured":"5. Inokuma S, Ikoma T, Inoue S, et al. Bucillamin induced lung injury in rheumatoid arthritis. Ryumachi 36: 34-42, 1996 (in Japanese, Abstract in English)."},{"key":"6","unstructured":"6. Inokuma S, Sakata M, Yoshida A, Shiratori K, Kiyosawa H. Bucillamine induced pulmonary injury occurs with immunoglobulin decrease. J Rheumatol 23: 1282-1285, 1996."},{"key":"7","unstructured":"7. Fukino K, Shiota S, Nakaya Y, et al. A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillaime. Kikansigaku (J Jpn Soc Respir Endosc) 19: 232-236, 1997 (in Japanese, Abstract in English)."},{"key":"8","unstructured":"8. Matsushima H, Takayanagi N, Sakamoto T, et al. A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine. Nihon Kokyuki Gakkai Zasshi (J Jpn Respir Soc) 39: 55-59, 2001 (in Japanese, Abstract in English)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lee YH, Kim YR, Ji JD, et al. A case of BOOP developed during bucillamine treatment for rheumatoid. Korean J Intern Med 16: 36-39, 2001.","DOI":"10.3904\/kjim.2001.16.1.36"},{"key":"10","unstructured":"10. Hagimoto N, Morooka M, Kuwano K, et al. Bucillamine-induced pneumonitis in a case with rheumatoid arthritis. Nihon Kyobu Rinsho (Jpn J Chest Dis) 61: 245-250, 2002 (in Japanese, Abstract in English)."},{"key":"11","unstructured":"11. Kishimoto N, Fujii K. A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi (J Jpn Respir Soc) 40: 321-325, 2002 (in Japanese, Abstract in English)."},{"key":"12","unstructured":"12. Tanimura K, Shimizu M, Matsuhashi M, Shinohara M, Sagawa A. A case of interstitial pneumonia caused by bucillamine: a study using serological markers. Mod Rheumatol 16: 39-43, 2006."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kajiya T, Kuroda A, Hokonohara D, Tei C. Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during Bucillamine treatment for rheumatoid arthritis. Am J Med Sci 332: 39-42, 2006.","DOI":"10.1097\/00000441-200607000-00008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nanke Y, Yamada T, Kamatani N. Asymptomatic interstitial pneumonitis induced by bucillamine in a patient with rheumatoid arthritis. Mod Rheumatol 15: 381-382, 2005.","DOI":"10.1007\/s10165-005-0417-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Saito Y, Nei T, Abe S, et al. A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes. Intern Med 46: 1739-1743, 2007.","DOI":"10.2169\/internalmedicine.46.0139"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ogiwara Y, Mochizuki H, Morioka T, Sugihara T, Makino F, Takahashi H. A case with life-threatening interstitial pneumonia associated with bucillamine treatment. Mod Rheumatol 18: 522-525, 2008.","DOI":"10.1007\/s10165-008-0083-7"},{"key":"17","unstructured":"17. Fujiwara K, Fujioka N, Teramoto K, et al. A case of drug-induced interstitial pneumonitis that occurred by the bucillamine administration to the rheumatic patient. Kokyu (Respiration Research) 31: 752-753, 2012 (in Japanese, Abstract in English)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nakamoto K, Tanaka Y, Sasaki Y, Goto H. Bucillamine-induced interstitial pneumonitis. J Gen Fam Med 19: 111-112, 2018.","DOI":"10.1002\/jgf2.169"},{"key":"19","unstructured":"19. Golden MR, Katz RS, Balk RA, Golden HE. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol 22: 1043-1047, 1995."},{"key":"20","unstructured":"20. Ohosone Y, Okano Y, Kameda H, et al. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis. J Rheumatol 24: 2299-2303, 1997."},{"key":"21","unstructured":"21. Zisman DA, McCune WJ, Tino G, Lynch JP 3rd. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 18: 243-252, 2001."},{"key":"22","unstructured":"22. Arakawa H, Yamasaki M, Kurihara Y, Yamada H, Nakajima Y. Methotrexate- induced pulmonary injury: serial CT findings. J Thorac Imaging 18: 231-236, 2003."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Suda T, Kaida Y, Nakamura Y, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 103: 846-853, 2009.","DOI":"10.1016\/j.rmed.2008.12.019"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med 194: 265-275, 2016.","DOI":"10.1164\/rccm.201604-0801CI"},{"key":"25","unstructured":"25. Silva CI, M\u00fcller NL, Fujimoto K, et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J Thorac Imaging 22: 221-229, 2007."},{"key":"26","doi-asserted-by":"crossref","first-page":"e003132","DOI":"10.1136\/bmjopen-2013-003132","volume":"3","author":"H Hozumi","year":"2013","unstructured":"26. Hozumi H, Nakamura Y, Johkoh T, et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 3: e003132, 2013.","journal-title":"BMJ Open","ISSN":"https:\/\/id.crossref.org\/issn\/2044-6055","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Olson AL, Gifford AH, Inase N, Fern\u00e1ndez P\u00e9rez ER, Suda T. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype. Eur Respir Rev 27: 180077, 2018.","DOI":"10.1183\/16000617.0077-2018"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Camus P, Degat OR, Justrabo E, Jeannin L. D-Penicillamine-induced severe pneumonitis. Chest 81: 376-378, 1982.","DOI":"10.1378\/chest.81.3.376"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Scott DL, Bradby GV, Aitman TJ, Zaphiropoulos GC, Hawkins CF. Relationship of gold and penicillamine therapy to diffuse interstitial lung disease. Ann Rheum Dis 40: 136-141, 1981.","DOI":"10.1136\/ard.40.2.136"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Eastmond CJ. Diffuse alveolitis as complication of penicillamine treatment for rheumatoid arthritis. Br Med J 1: 1506, 1976.","DOI":"10.1136\/bmj.1.6024.1506"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Petersen J, M\u00f8ller I. Miliary pulmonary infiltrates and penicillamine. Br J Radiol 51: 915-916, 1978.","DOI":"10.1259\/0007-1285-51-611-915"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Davies D, Jones JK. Pulmonary eosinophilia caused by penicillamine. Thorax 35: 957-958, 1980.","DOI":"10.1136\/thx.35.12.957"},{"key":"33","unstructured":"33. Hayashi S, Hirose N, Ikeda T, Shigematsu N. A case of prolonged pulmonary eosinophilia caused by D-penicillamine. Nihon Kyobu Shikkan Gakkai Zasshi (J Jpn Respir Soc) 23: 479-484, 1985 (in Japanese, Abstract in English)."},{"key":"34","unstructured":"34. Seo JY, Kim SY, Choi WC. Education and imaging. Hepatobiliary and pancreatic: hypersensitivity pneumonitis induced by penicillamine. J Gastroenterol Hepatol 24: 700, 2009."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/15\/58_2515-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T14:06:49Z","timestamp":1663164409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/15\/58_2515-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2515-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}